GC
BNTX icon

Guggenheim Capital’s BioNTech BNTX Stock Holding History

Guggenheim Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
20,705
+1,294
+7% +$122K 0.01% 749
2026
Q1 		$1.73M Buy
19,411
+3,517
+22% +$361K 0.01% 752
2025
Q4 		$1.51M Buy
15,894
+2,870
+22% +$289K 0.01% 764
2025
Q3 		$1.28M Buy
13,024
+1,102
+9% +$118K 0.01% 832
2025
Q2 		$1.27M Sell
11,922
-1,863
-14% -$188K 0.01% 801
2025
Q1 		$1.26M Buy
13,785
+2,732
+25% +$306K 0.01% 797
2024
Q4 		$1.26M Sell
11,053
-2,137
-16% -$244K 0.01% 814
2024
Q3 		$1.57M Sell
13,190
-9
-0.1% -$827 0.01% 909
2024
Q2 		$1.06M Sell
13,199
-7,971
-38% -$729K 0.01% 1091
2024
Q1 		$1.95M Buy
21,170
+2,971
+16% +$285K 0.01% 891
2023
Q4 		$1.92M Sell
18,199
-853
-4% -$86K 0.01% 862
2023
Q3 		$2.07M Sell
19,052
-3,965
-17% -$439K 0.02% 801
2023
Q2 		$2.48M Buy
23,017
+6,489
+39% +$730K 0.02% 768
2023
Q1 		$2.06M Buy
16,528
+1,247
+8% +$171K 0.02% 836
2022
Q4 		$2.3M Sell
15,281
-2,328
-13% -$358K 0.02% 806
2022
Q3 		$2.38M Sell
17,609
-3,189
-15% -$488K 0.02% 774
2022
Q2 		$3.1M Sell
20,798
-3,473
-14% -$531K 0.02% 730
2022
Q1 		$4.14M Buy
24,271
+3,256
+15% +$547K 0.02% 723
2021
Q4 		$5.42M Buy
21,015
+6,294
+43% +$1.72M 0.03% 654
2021
Q3 		$4.02M Sell
14,721
-1,944
-12% -$618K 0.02% 746
2021
Q2 		$3.73M Sell
16,665
-15,628
-48% -$2.95M 0.02% 794
2021
Q1 		$3.53M Sell
32,293
-2,502
-7% -$266K 0.02% 774
2020
Q4 		$2.84M Buy
+34,795
New +$3.42M 0.02% 815

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Guggenheim Capital's BNTX Position: Q2 2026 in Review

Guggenheim Capital increased its BioNTech (BNTX) stake by 6.7% in Q2 2026, buying an estimated $122K and bringing the position to 20,705 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #749.

Guggenheim Capital first reported a position in BNTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.42M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Guggenheim Capital held 20,705 shares of BioNTech worth $1.93M as of Q2 2026.
  • Guggenheim Capital bought 1,294 BioNTech shares in Q2 2026, an estimated $122K.
  • BioNTech made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #749 holding.
  • Guggenheim Capital first reported a position in BioNTech in Q4 2020 and has held it in 23 quarters since.
  • Guggenheim Capital's BioNTech position peaked at $5.42M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.